Literature DB >> 26164592

Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments.

L Felice Reddy1, William P Horan2, Michael F Green2.   

Abstract

Recent years have seen a resurgence of interest in motivational disturbances in schizophrenia . This is largely driven by the recognition that these disturbances are central to the "experiential" subdomain of negative symptoms and are particularly important determinants of functional disability. Research into the causes and treatment of experiential negative symptoms is therefore a high priority. This chapter reviews findings from experimental psychopathology and affective science relevant to understanding the neurobehavioral processes that underlie these negative symptoms. We focus on abnormalities in four processes that have received the most attention as likely contributors: anticipatory pleasure, reward learning, effort-based decision-making, and social motivation. We also review the research literature on pharmacological and psychosocial approaches to reduce functional deficits attributable to negative symptoms. Translational research is beginning to inform the development of new treatments specifically designed to target the experiential subdomain of negative symptoms.

Entities:  

Keywords:  Effort-based decision-making; Motivation; Negative symptoms; Neurobehavioral; Reward learning; Schizophrenia; Social motivation

Mesh:

Year:  2016        PMID: 26164592     DOI: 10.1007/7854_2015_379

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  18 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

Review 3.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

4.  Motivational and cognitive correlates of community integration in homeless veterans entering a permanent supported housing program.

Authors:  William P Horan; Jonathan K Wynn; Sonya Gabrielian; Shirley M Glynn; Gerhard S Hellemann; Robert S Kern; Junghee Lee; Stephen R Marder; Catherine A Sugar; Michael F Green
Journal:  Am J Orthopsychiatry       Date:  2019-04-25

5.  Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report.

Authors:  Melissa Fisher; Mor Nahum; Elizabeth Howard; Abby Rowlands; Benjamin Brandrett; Amy Kermott; Joshua Woolley; Sophia Vinogradov
Journal:  Psychiatr Rehabil J       Date:  2017-03

6.  Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs.

Authors:  Gemma L Dalton; Stan B Floresco; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2021-01-11       Impact factor: 4.530

7.  Altered experiential, but not hypothetical, delay discounting in schizophrenia.

Authors:  William P Horan; Matthew W Johnson; Michael F Green
Journal:  J Abnorm Psychol       Date:  2017-02-06

Review 8.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

Review 9.  Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

Authors:  John D Salamone; Samantha E Yohn; Laura López-Cruz; Noemí San Miguel; Mercè Correa
Journal:  Brain       Date:  2016-05       Impact factor: 13.501

10.  Serum BDNF Is Positively Associated With Negative Symptoms in Older Adults With Schizophrenia.

Authors:  Sasha S Binford; Erin M Hubbard; Elena Flowers; Bruce L Miller; Heather Leutwyler
Journal:  Biol Res Nurs       Date:  2017-10-19       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.